114 related articles for article (PubMed ID: 6542869)
21. Influence of bromocriptine and oestrogen on prolactin synthesis, secretion and tumour growth in vivo in rats.
Vrontakis ME; Thliveris JA; Friesen HG
J Endocrinol; 1987 Jun; 113(3):383-8. PubMed ID: 3625096
[TBL] [Abstract][Full Text] [Related]
22. Lactogenic actions of different growth hormone preparations in pregnant and lactating rats.
Carón RW; Jahn GA; Deis RP
J Endocrinol; 1994 Sep; 142(3):535-45. PubMed ID: 7964304
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of prolactin in the last trimester of gestation decreases mammary gland development in gilts.
Farmer C; Sorensen MT; Petitclerc D
J Anim Sci; 2000 May; 78(5):1303-9. PubMed ID: 10834586
[TBL] [Abstract][Full Text] [Related]
24. [Inhibition of prolactin release by methysergide and bromocriptine in hyperprolactinemic subjects: comparative dynamic studies (author's transl)].
Fossati P; Dewailly D; Lemaire A; Cappoen JP; Wemeau JL; Fourlinnie JC; Linquette M
Ann Endocrinol (Paris); 1980; 41(1):55-6. PubMed ID: 7396395
[TBL] [Abstract][Full Text] [Related]
25. Quercetin improves postpartum hypogalactia in milk-deficient mice via stimulating prolactin production in pituitary gland.
Lin M; Wang N; Yao B; Zhong Y; Lin Y; You T
Phytother Res; 2018 Aug; 32(8):1511-1520. PubMed ID: 29671937
[TBL] [Abstract][Full Text] [Related]
26. Suckling-induced prolactin release potentiates mifepristone-induced lactogenesis in pregnant rats.
Deis RP; Carrizo DG; Jahn GA
J Reprod Fertil; 1989 Sep; 87(1):147-53. PubMed ID: 2621690
[TBL] [Abstract][Full Text] [Related]
27. Experimental manipulations of prolactin following removal of pouch young or bromocriptine treatment during lactational quiescence in the Bennett's wallaby.
Curlewis JD; Loudon AS
J Endocrinol; 1988 Dec; 119(3):405-11. PubMed ID: 3221153
[TBL] [Abstract][Full Text] [Related]
28. Rat prolactin synthesis by lactating mammary epithelial cells.
Lkhider M; Delpal S; Le Provost F; Ollivier-Bousquet M
FEBS Lett; 1997 Jan; 401(2-3):117-22. PubMed ID: 9013870
[TBL] [Abstract][Full Text] [Related]
29. Fine structure of rat prolactin cells after treatment with a long acting depot contraceptive.
Aumüller G; Wagner R; Gräf KJ
Acta Endocrinol (Copenh); 1978 Oct; 89(2):251-62. PubMed ID: 696178
[TBL] [Abstract][Full Text] [Related]
30. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
[TBL] [Abstract][Full Text] [Related]
31. Abnormal prolactin levels and pituitary-gonadal axis in the puerperium.
Andersen AN; Tabor A; Hertz JB; Schiøler V
Obstet Gynecol; 1981 Jun; 57(6):725-9. PubMed ID: 7231824
[TBL] [Abstract][Full Text] [Related]
32. Control of rat mammary-gland pyruvate dehydrogenase by insulin and prolactin.
Field B; Coore HG
Biochem J; 1976 May; 156(2):333-7. PubMed ID: 133680
[TBL] [Abstract][Full Text] [Related]
33. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
Hirvonen E; Ranta T; Seppäla M
J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
[TBL] [Abstract][Full Text] [Related]
34. Bromocriptine treatment of periparturient goats: long-term suppression of prolactin and lack of effect on lactation.
Forsyth IA; Lee PD
J Dairy Res; 1993 Aug; 60(3):307-17. PubMed ID: 7690787
[TBL] [Abstract][Full Text] [Related]
35. Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment.
Tørring O; Isberg B; Sjöberg HE; Bucht E; Hulting AL
Acta Endocrinol (Copenh); 1993 May; 128(5):423-7. PubMed ID: 8317189
[TBL] [Abstract][Full Text] [Related]
36. Mammary growth during pregnancy in hypophysectomized or bromocriptine-treated goats.
Buttle HL; Cowie AT; Jones EA; Turvey A
J Endocrinol; 1979 Mar; 80(3):343-51. PubMed ID: 438710
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
Sabuncu T; Arikan E; Tasan E; Hatemi H
Intern Med; 2001 Sep; 40(9):857-61. PubMed ID: 11579944
[TBL] [Abstract][Full Text] [Related]
38. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
[TBL] [Abstract][Full Text] [Related]
39. Hyperprolactinemia. Long-term effects of bromocriptine.
Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
[TBL] [Abstract][Full Text] [Related]
40. Hyperprolactinemic response after bromocriptine withdrawal in women with prolactin-secreting pituitary tumors.
Maxson WS; Dudzinski M; Handwerger SH; Hammond CB
Fertil Steril; 1984 Feb; 41(2):218-23. PubMed ID: 6698215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
